Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Melatonin in Intrauterine Growth Restriction
IRCT20170515033976N3Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in intrauterine growth restriction (IUGR), sponsored by Shiraz University of Medical Sciences. Started Apr 2026; status: completed.
02
Drugs
melatonin
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on IRCT20170515033976N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170515033976N3.